285 related articles for article (PubMed ID: 29065866)
1. Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications.
Yang W; Li Y; Tian T; Wang L; Lee P; Hua Q
BMC Endocr Disord; 2017 Oct; 17(1):67. PubMed ID: 29065866
[TBL] [Abstract][Full Text] [Related]
2. Serum Vaspin Concentration in Elderly Type 2 Diabetes Mellitus Patients with Differing Body Mass Index: A Cross-Sectional Study.
Yang W; Li Y; Tian T; Wang L
Biomed Res Int; 2017; 2017():4875026. PubMed ID: 28553648
[No Abstract] [Full Text] [Related]
3. Role of serum vaspin in progression of type 2 diabetes: a 2-year cohort study.
Jian W; Peng W; Xiao S; Li H; Jin J; Qin L; Dong Y; Su Q
PLoS One; 2014; 9(4):e94763. PubMed ID: 24732788
[TBL] [Abstract][Full Text] [Related]
4. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
5. Vaspin serum concentration in patients with type 2 diabetes and carotid plaque.
Li Z; Ma C; Li L; Pan X; Chen L
J Int Med Res; 2012; 40(5):1670-6. PubMed ID: 23206449
[TBL] [Abstract][Full Text] [Related]
6. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications.
Gulcelik NE; Karakaya J; Gedik A; Usman A; Gurlek A
Eur J Endocrinol; 2009 Jan; 160(1):65-70. PubMed ID: 18952766
[TBL] [Abstract][Full Text] [Related]
7. Association between vaspin level and coronary artery disease in patients with type 2 diabetes.
Hao F; Zhang H; Zhu J; Kuang H; Yu Q; Bai M; Mu J
Diabetes Res Clin Pract; 2016 Mar; 113():26-32. PubMed ID: 26972957
[TBL] [Abstract][Full Text] [Related]
8. Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity.
Li K; Li L; Yang M; Liu H; Liu D; Yang H; Boden G; Yang G
Eur J Endocrinol; 2011 Jun; 164(6):905-10. PubMed ID: 21471167
[TBL] [Abstract][Full Text] [Related]
9. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
10. Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes.
Yang L; Chen SJ; Yuan GY; Wang D; Chen JJ
Genet Mol Res; 2015 Sep; 14(3):11356-61. PubMed ID: 26436376
[TBL] [Abstract][Full Text] [Related]
11. Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus.
El-Lebedy DH; Ibrahim AA; Ashmawy IO
Diabetes Metab Syndr; 2018 Sep; 12(5):643-648. PubMed ID: 29673927
[TBL] [Abstract][Full Text] [Related]
12. Association of vaspin gene expression and its serum level on the risk of ischemic stroke in type 2 diabetic Egyptian patients: Prospective case-control study.
Rashad NM; Ahmed HS; Ashour WMR; Yousef MS
Biotechnol Appl Biochem; 2020 Nov; 67(6):912-919. PubMed ID: 31706261
[TBL] [Abstract][Full Text] [Related]
13. Serum Levels of Vaspin and Its Correlation with Nitric Oxide in Type 2 Diabetic Patients with Nephropathy.
Mihanfar A; Rahmati-Yamchi M; Mota A; Abediazar S; Pilehvar-Soltanahmadi Y; Zarghami N
Curr Diabetes Rev; 2018; 14(2):162-167. PubMed ID: 28554309
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: a retrospective study.
Yang W; Li Y; Wang JY; Han R; Wang L
Cardiovasc Diabetol; 2018 May; 17(1):75. PubMed ID: 29848323
[TBL] [Abstract][Full Text] [Related]
15. Experimental type 2 diabetes induction reduces serum vaspin, but not serum omentin, in Wistar rats.
Castro CA; da Silva KA; Buffo MM; Pinto KNZ; Duarte FO; Nonaka KO; Aníbal FF; Duarte ACGO
Int J Exp Pathol; 2017 Feb; 98(1):26-33. PubMed ID: 28444853
[TBL] [Abstract][Full Text] [Related]
16. Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes.
Ye Y; Hou XH; Pan XP; Lu JX; Jia WP
Chin Med J (Engl); 2009 Nov; 122(21):2530-3. PubMed ID: 19951565
[TBL] [Abstract][Full Text] [Related]
17. Elevated circulating vaspin levels were decreased by rosiglitazone therapy in T2DM patients with poor glycemic control on metformin alone.
Zhang L; Li L; Yang M; Liu H; Yang G
Cytokine; 2011 Nov; 56(2):399-402. PubMed ID: 21802961
[TBL] [Abstract][Full Text] [Related]
18. The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
Xu J; Liao YF; Zhou WP; Ming HL; Wang QH
Genet Test Mol Biomarkers; 2015 Aug; 19(8):411-7. PubMed ID: 26083329
[TBL] [Abstract][Full Text] [Related]
19. Serum vaspin concentrations in human obesity and type 2 diabetes.
Youn BS; Klöting N; Kratzsch J; Lee N; Park JW; Song ES; Ruschke K; Oberbach A; Fasshauer M; Stumvoll M; Blüher M
Diabetes; 2008 Feb; 57(2):372-7. PubMed ID: 17991760
[TBL] [Abstract][Full Text] [Related]
20. Association of serum vaspin and adiponectin levels with renal function in patients with or without type 2 diabetes mellitus.
Yan M; Su B; Peng W; Li L; Li H; Zhuang J; Lu Y; Jian W; Wei Y; Li W; Qu S; Xu Y
J Diabetes Res; 2014; 2014():868732. PubMed ID: 25133192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
